Stada says it is taking steps to address current supply disruptions for tamoxifen in Germany, by importing supplies from its Italian EG unit into the German market through its Aliud Pharma subsidiary.
Shortages of the breast cancer drug in Germany were recently highlighted by off-patent industry association Medicines for Europe (see sidebar).




